JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2013, Vol. 51 ›› Issue (1): 109-112.

• Articles • Previous Articles    

The retrospective analysis of 53 patients with bisphosphonate-related osteonecrosis of the jaw

LI Yin-zhu1, XU Wen-jun2, CUI Jing-ying2, REN Cui-ai2   

  1. 1. Wei Fang Medical Colleage; 2. Department of Hematology,Weifang People’s Hospital, Weifang 261000, Shandong, China
  • Received:2012-05-28 Online:2013-01-10 Published:2013-01-10

Abstract:

Objective   To explore the clinical manifestations and treatments of bisphosphonate-related osteonecrosis of the jaw. Methods   The clinical manifestations、 diagnostic and treatments of 53 multiple myeloma cases of bisphosphonate-related osteonecrosis of the jaw admitted to our hospital between 2005-2011 were analyzed retrospectively. Results   53 patients were all treated with antibiotics. 12 patients of them were performed with bone debridement/palliative surgeries, 12 patients were performed with bone debridement/palliative surgeries in association with ozone treatment and 14 patients were performed with ozone treatment. 26 patients were performed in association with ozone treatment,27 patients weren’t performed in association with ozone treatment.The efficient treated with antibiotics alone was 60%, the antibiotic therapy in association with surgeries was 58.4%, in association with ozone treatment was 92.3%, no ozone treatment was 59.2%. Conclusion   Antibiotics can control disease progression in BRONJ patients, the remission rate treated by antibiotics combined with surgeries is not significantly higher than that treated by antibiotics alone, and will affect the quality of life of patients. We recommend conservative treatment in BRONJ patients.In addition, ozone treatment, compared with other treatments, has significantly higher efficiency, so its clinical application is proposed.

Key words: Bisphosphonate-related osteonecrosis of the jaw; Antibiotic; Bone debridement/palliative surgeries; Ozone treatment

CLC Number: 

  • R733.3
[1] PU Ye-di, LI Li-zhen, MA Dao-xin, DONG Ke,ZHAO Chuan-li, SONG Qiang, WANG Lu-qun. Establishment of a bortezomib-resistant cell line KM3/BTZ of human multiple myeloma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 33-.
[2] ZHANG Jing-jing, MA Dao-xin, KONG Hai-li, WANG Hui-jun, SUN Yuan-xin, LIU Chuan-fang. AML1/ETO siRNA enhances the sensitivity of Kasumi-1 cells to  histone acetylation enzyme inhibitors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(7): 68-73.
[3] ZHAO Ting,SONG Qiang, LI Li-zhen,WANG Lu-qun, ZHAO Chuan-li. Level of etythropoietin and expression of the etythropoietin  receptor in Myelodysplastic Syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(1): 67-70.
[4] LU Fei, LIU Chuanfang, MA Daoxin, LIU Yanping,KONG Haili, ZHANG Jingjing. Effect of 5-Aza-2′-deoxycytidine on SOCS-1 gene expression, proliferation and apoptosis in RPMI8226 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(4): 45-.
[5] LI Shan, LI Li-zhen, SONG Qiang, ZHAO Chuan-li, YAN Shu-xin, WANG Lu-qun. Effects of honokiol and Bortezomib on proliferation and  apoptosis in myeloma KM3 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(12): 32-36.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!